GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Bio-Gene Technology BGT.AX · AUD

Materials · ASX · 🇦🇺 Australia

Compare

0.01

—

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Bio-Gene Technology — daily ASX:BGT

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Bio-Gene Technology on TradingView ↗
Market value
A$4.0m
Last close × shares

About Bio-Gene Technology

Its shares trade on ASX under the ticker BGT.AX. It has been listed since 29 November 2017. In the fiscal year to 30 June 2025, it reported revenue of A$425,070 and a net loss of A$2.6m. At that date it held total assets of A$2.1m and shareholders' equity of A$1.6m.

Bio-Gene Technology Ltd. is a development company enabling the next generation of novel insecticides, addressing the problems of insecticide resistance and toxicity. The company is headquartered in Melbourne, Victoria. The company went IPO on 2017-11-29. The Company’s principal activity is to develop and commercialize insecticides/pesticides. Its platform technology is based on a naturally occurring class of chemicals known as beta-triketones, that seeks to address the global problems of insecticide resistance and toxicity. The firm's lead beta-triketone insecticide products include Flavocide and Qcide. Flavocide is a chemically synthesized product based on flavesone. Qcide is a natural oil product containing tasmanone as the active constituent. The oil is extracted from the leaves of the Gympie Messmate, by utilizing a steam distillation process. Its platform provides multiple solutions for insecticide manufacturers in applications across crop protection and storage, public health, animal health and consumer applications. The firm also aims to develop and commercialize a portfolio of targeted insect control and management solutions.

Figures and description from our data supplier, not checked against the company's own report.

More about Bio-Gene Technology →

Latest on Bio-Gene Technology

Our reporting

We have not reported on Bio-Gene Technology yet.

Next results

3 Mar 2027

Due on 3 Mar 2027.

Other Materials listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Bio-Gene Technology's ticker?

Bio-Gene Technology trades as BGT.AX on ASX, under ISIN AU000000BGT8.

What was Bio-Gene Technology's last closing price?

0.01 on 9 Nov 2026. The figure is in AUD and is never converted.

When does Bio-Gene Technology next report results?

Results are expected on 3 Mar 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.